Synthesis and biological activities of novel pyrrolo[1,2-d][1,2,4]triazin-1(2H)-one derivatives

References

• Pudziuvelyte, E.; Ríos-Luci, C.; León, L. G.; Cikotiene, I.; Padrón, J. M. Synthesis and Antiproliferative Activity of 2,4-Disubstituted 6-Aryl-7H-Pyrrolo[3,2-d]Pyrimidin-7-One 5-Oxides. Bioorg. Med. Chem. 2009, 17, 4955–4960. DOI: 10.1016/j.bmc.2009.05.078.
   PubMed Web of Science ®Google Scholar
• Anderson, W. K.; Dean, D. C.; Endo, T. Synthesis, Chemistry, and Antineoplastic Activity of Alpha-Halopyridinium Salts: potential Pyridone Prodrugs of Acylated Vinylogous Carbinolamine Tumor Inhibitors. J. Med. Chem. 1990, 33, 1667–1675. DOI: 10.1021/jm00168a021.
   PubMed Web of Science ®Google Scholar
• Anderson, W. K.; Mach, R. Synthesis, Chemical Reactivity, and Antileukemic Activity of 5-Substituted 6,7-Bis(Hydroxymethyl)Pyrrolo[1,2-c]Thiazole Biscarbamates and the Corresponding Sulfoxides and Sulfones. J. Med. Chem. 1987, 30, 2109–2115. DOI: 10.1021/jm00394a030.
   PubMed Web of Science ®Google Scholar
• Orlemans, E. O.; Verboom, W.; Scheltinga, M. W.; Reinhoudt, D. N.; Lelieveld, P.; Fiebig, H. H.; Winterhalter, B. R.; Double, J. A.; Bibby, M. C. Synthesis, Mechanism of Action, and Biological Evaluation of Mitosenes. J. Med. Chem. 1989, 32, 1612–1620. DOI: 10.1021/jm00127a035.
   PubMed Web of Science ®Google Scholar
• Kadushkin, A. V.; Golovko, T. V.; Kalistratov, S. G.; Sokolova, A. S. Lactam and Acid Amide Acetals 65. Study of the Reaction of DMF Diethylacetal with 5-Carbamoyl(Thiocarbamoyl)-6-Aminopyrrolizine Derivatives. Chem. Pharm. J. 1987, 5, 545. DOI: 10.1007/BF00474230.
   Google Scholar
• Anderson, W. K.; McPherson, H. L.; New, J. S.; Rick, A. C. Synthesis and Murine Antineoplastic Activity of Bis[(Carbamoyloxy)Methyl] Derivatives of Pyrrolo[2,1-a]Isoquinoline . J. Med. Chem. 1984, 27, 1321–1325. DOI: 10.1021/jm00376a017.
   PubMed Web of Science ®Google Scholar
• Anderson, W. K.; Heider, A. R.; Raju, N.; Yucht, J. A. Synthesis and Antileukemic Activity of Bis[[(Carbamoyl)oxy]methyl]- Substituted Pyrrolo[2,1-a]Isoquinolines, Pyrrolo[1,2-a]quinolines, Pyrrolo[2,1-a]isobenzazepines, and Pyrrolo[1,2-a]benzazepines. J. Med. Chem. 1988, 31, 2097. DOI: 10.2102.1/jm00119a008.
   PubMed Web of Science ®Google Scholar
• Islam, I.; Skibo, E. B.; Dorr, R. T.; Alberts, D. S. Structure-Activity Studies of Antitumor Agents Based on Pyrrolo[1,2-a]Benzimidazoles: new Reductive Alkylating DNA Cleaving Agents. J. Med. Chem. 1991, 34, 2954–2961. DOI: 10.1021/jm00114a003.
   PubMed Web of Science ®Google Scholar
• Baraldi, P. G.; Leoni, A.; Cacciari, B.; Manfredini, S.; Simoni, D. Synthesis and Antitumor Activity of a New Class of Pyrazolo[4,3-e]Pyrrolo[1,2-a][1,4]Diazepinone Analogs of Pyrrolo[1,4]Benzodiazepines (PBDs). Bioorg. Med. Chem. Lett. 1993, 3, 2511–2514. DOI: 10.1016/S0960-894X(01)80707-1.
   Web of Science ®Google Scholar
• Hu, W.-P.; Liang, J.-J.; Kao, C.-L.; Chen, Y.-C.; Chen, C.-Y.; Tsai, F.-Y.; Wu, M.-J.; Chang, L.-S.; Chen, Y.-L.; Wang, J.-J. Synthesis and Antitumor Activity of Novel Enediyne-Linked Pyrrolo[2,1-c][1,4]Benzodiazepine Hybrids. Bioorg. Med. Chem. 2009, 17, 1172–1180. DOI: 10.1016/j.bmc.2008.12.036.
   PubMed Web of Science ®Google Scholar
• Malinka, W.; Redzicka, A.; Lozach, O. New Derivatives of Pyrrolo[3,4-d]Pyridazinone and Their Anticancer Effects. Farmaco. 2004, 59, 457–462. DOI: 10.1016/j.farmac.2004.03.002.
   PubMedGoogle Scholar
• Ghorab, M. M.; Ragab, F. A.; Heiba, H. I.; Youssef, H. A.; El-Gazzar, M. G. Synthesis of Novel Pyrrole and Pyrrolo[2,3-d]Pyrimidine Derivatives Bearing Sulfonamide Moiety for Evaluation as Anticancer and Radiosensitizing Agents. Bioorg. Med. Chem. Lett. 2010, 20, 6316–6320. DOI: 10.1016/j.bmcl.2010.08.005.
   PubMed Web of Science ®Google Scholar
• Diana, P.; Barraja, P.; Lauria, A.; Montalbano, A.; Almerico, A. M.; Dattolo, G.; Cirrincione, G. Pyrrolo[2,1-d][1,2,3,5]Tetrazine-4(3H)-Ones, a New Class of Azolotetrazines with Potent Antitumor Activity. Eur. J. Med. Chem. 2002, 37, 267–272. DOI: 10.1016/s0968-0896(03)00145-7.
   PubMed Web of Science ®Google Scholar
• Alleca, S.; Corona, P.; Loriga, M.; Paglietti, G.; Loddo, R.; Mascia, V.; Busonera, B.; La Colla, P. Quinoxaline Chemistry. Part 16. 4-Substituted Anilino and 4-Substituted Phenoxymethyl Pyrrolo[1,2-a]Quinoxalines and N-[4-(Pyrrolo[1,2-a]Quinoxalin-4-yl)Amino and Hydroxymethyl]Benzoyl Glutamates. Synthesis and Evaluation of in Vitro Biological Activity. II Farmaco 2003, 58, 639–650. DOI: 10.1016/s0014-827x(03)00101-0.
   PubMedGoogle Scholar
• Chen, Q.; Dai, J.; Chen, X.; Sun, M.; Sun, H.; Wang, F.; Chen, L.; Kong, L. Pyrrolo[2,1-f][1,2,4]Triazine Derivative, and Preparation Method and Use Thereof. WO Patent WO2015081783 A1, June 11, 2015.
   Google Scholar
• Dzierba, C. D.; Dasgupta, B.; Macor, J. E.; Bronson, J. J.; Rajamani, R.; Karageorge, G. N. Pyrrolotriazine Kinase Inhibitors. WO Patent WO 2,015,054,358 A1, April 16, 2015.
   Google Scholar
• Lim, J.; Altman, M. D.; Baker, J.; Brubaker, J. D.; Chen, H.; Chen, Y.; Kleinschek, M. A.; Li, C.; Liu, D.; Maclean, J. K. F.; et al. Identification of N-(1H-Pyrazol-4-yl)Carboxamide Inhibitors of Interleukin-1 Receptor Associated Kinase 4: Bicyclic Core Modifications. Bioorg. Med. Chem. Lett. 2015, 25, 5384–5388. DOI: 10.1016/j.bmcl.2015.09.028.
   PubMed Web of Science ®Google Scholar
• Mesaros, E. F.; Angeles, T. S.; Albom, M. S.; Wagner, J. C.; Aimone, L. D.; Wan, W.; Lu, L.; Huang, Z.; Olsen, M.; Kordwitz, E.; et al. Piperidine-3,4-Diol and Piperidine-3-ol Derivatives of Pyrrolo[2,1-f][1,2,4]Triazine as Inhibitors of Anaplastic Lymphoma Kinase. Bioorg. Med. Chem. Lett. 2015, 25, 1047–1052. DOI: 10.1016/j.bmcl.2015.01.019.
   PubMed Web of Science ®Google Scholar
• Tyndall, E. M.; Draffan, A. G.; Frey, B.; Pool, B.; Halim, R.; Jahangiri, S.; Bond, S.; Wirth, V.; Luttick, A.; Tilmanis, D.; et al. Prodrugs of Imidazotriazine and Pyrrolotriazine C-Nucleosides Can Increase anti-HCV Activity and Enhance Nucleotide Triphosphate Concentrations in Vitro. Bioorg. Med. Chem. Lett. 2015, 25, 869–873. DOI: 10.1016/j.bmcl.2014.12.069.
   PubMed Web of Science ®Google Scholar
• Su, W.-G.; Dai, G.; Xiao, K.; Jia, H.; Venable, J. D.; Bembenek, S. D. Novel Heteroaryl and Heterocycle Compounds, Compositions and Methods. WO Patent WO2014015675 A1, 2014. Jan 30.
   Google Scholar
• Castro, A. C.; Chan, K.; Evans, C. A.; Janardanannair, S.; Lescarbeau, A.; Li, L.; Liu, T.; Liu, Y.; Ren, P.; Snyder, D. A.; et al.. Heterocyclic Compounds and Uses Thereof. U.S. Patent US 20,130,267,521 A1, October 10, 2013.
   Google Scholar
• Bernal Anchuela, F. J.; Carrascal Riere, M.; Caturla Javaloyes, J. F.; Gracia Ferrer, J.; Matassa, V. G. Terricabras Belart, E. Pyrrolotiazinone Derivatives as PI3K Inhibitors. European Patent EP2518070 A1, October 31, 2012.
   Google Scholar
• Carrera Carrera, F.; Perez Garcia, J. B.; Vidal Juan, B.; Sanchez Izquierdo, F.; Serra Coma, M. C. (S)-2-(1-(6-Amino-5-Cyanopyrimidin-4-ylamino)Ethyl)-4-oxo-3-phenyl-3, 4-Dihydropyrrolo[1,2-f][1,2,4]Triazine-5-Carbonitrile. WO Patent WO2015181052 A1, December 3, 2015.
   Google Scholar
• Liu, C.; Lin, J.; Wrobleski, S. T.; Lin, S.; Hynes, J.; Wu, H.; Dyckman, A. J.; Li, T.; Wityak, J.; Gillooly, K. M.; et al. Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-Methylphenylamino)-5-methyl-N-Propylpyrrolo[1,2-f][1,2,4]Triazine-6-Carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory Diseases. J. Med. Chem. 2010, 53, 6629–6639. DOI: 10.1021/jm100540x.
   PubMed Web of Science ®Google Scholar
• Eugen, F. M.; Tho, V. T.; Gregory, J. W.; Craig, A. Z. Strategies to Mitigate the Bioactivation of 2-Anilino-7-Aryl-Pyrrolo[2,1-f][1,2,4]Triazines: Identification of Orally Bioavailable, Efficacious ALK Inhibitors. J. Med. Chem. 2012, 55, 115. DOI: 10.1021/jm2010767.
   PubMed Web of Science ®Google Scholar
• Valeriia, A.; Astakhina, A.; Maxim, V.; Olexander, K.; Vladimir, N.; Elena, K. P.; Olena, P. Synthesis and Biological Activity of Novel Ethyl Esters of 4‐R‐6,8‐Dimethyl‐1‐Oxo‐1,2‐Dyhi dropyrrolo[1,2‐d] [1,2,4]Triazine‐7‐Carboxylic Acids. J. Heterocycl. Chem. 2016, 53, 421. DOI: 10.1002/jhet.2204..
   Web of Science ®Google Scholar
• Lancelot, J. C.; Maume, D.; Robba, M. Pyrrolo[1,2‐d] Triazines‐1,2,4. I. Pyrrolic Derivatives. J. Heterocycl. Chem. 1980, 17, 625–629. DOI: 10.1002/jhet.5570170401.
   Web of Science ®Google Scholar
• James, R. M.; Dan, A. W.; Alan, C. W.; Virgil, I. S. Synthesis of 5-Aryl-2H-Tetrazoles, 5-Aryl-2H-Tetrazole-2-Acetic Acids, and [(4-Phenyl-5-Aryl-4H-1,2,4-Triazol-3-yl)Thio]Acetic Acids as Possible Superoxide Scavengers and Antiinflammatory Agents. J. Med. Chem. 1984, 27, 1565. DOI: 10.1021/jm00378a007..
   PubMed Web of Science ®Google Scholar
• Arduengo, A. J.; Krafczyk, R.; Schmutzler, R.; Craig, H. A.; Goerlich, J. R.; Marshall, W. J.; Unverzagt, M. Imidazolylidenes, Imidazolinylidenes and Imidazolidines. Tetrahedron. 1999, 55, 14523–14534. DOI: 10.1016/S0040-4020(99)00927-8.
   Web of Science ®Google Scholar
• Gilow, M.; Edward, D. B. Bromination and Chlorination of Pyrrole and Some Reactive 1-Substituted Pyrroles. J. Org. Chem. 1981, 46, 2221–2225. DOI: 10.1021/jo00324a005.
   Web of Science ®Google Scholar
• Valerie, G. R.; Ian, S.; Jenny, L. P.; Darren, R. Immobilized Tetrakis(Triphenylphosphine)Palladium(0) for Suzuki–Miyaura Coupling Reactions under Flow Conditions. React. Chem. Eng. 2019, 4, 372. DOI: 10.1039/C8RE00235E.
   Web of Science ®Google Scholar
• Joshua, R. D.; Javier, M.; Gerald, A. W. Large-Scale Applications of Amide Coupling Reagents for the Synthesis of Pharmaceuticals. Org. Process Res. Dev. 2016, 20, 140. DOI: 10.1021/op500305s..
   Web of Science ®Google Scholar
• (a) Andrews, D. M.; Arnould, J.-C.; Boutron, P.; Délouvrie, B.; Delvare, C.; Foote, K. M.; Hamon, A.; Harris, C. S.; Lambert-van der Brempt, C.; Lamorlette, M.; Matusiak, Z. M. Fischer Synthesis of Isomeric Thienopyrrole LHRH Antagonists. Tetrahedron. 2009, 65, 5805–5816. DOI: 10.1016/j.tet.2009.05.007. (b) O’Shea, P. D.; Chen, C. Y.; Gauvreau, D.; Gosselin, F.; Hughes, G.; Nadeau, C.; Volante, R. P. A Practical Enantioselective Synthesis of Odanacatib, a Potent Cathepsin K Inhibitor, via Triflate Displacement of an α-Trifluoromethylbenzyl Triflate. J. Org. Chem. 2009, 74, 1605. DOI: 10.1021/jo8020314.
   Web of Science ®Google Scholar
• Valgas, C.; Souza, S. M.; Smânia, F. A.; Smânia, A. Screening Methods to Determine Antibacterial Activity of Natural Products. Braz. J. Microbiol. 2007, 38, 369–380. DOI: 10.1590/S1517-83822007000200034.
   Web of Science ®Google Scholar
• Wiegand, I.; Hilpert, K.; Robert, E. W. Agar and Broth Dilution Methods to Determine the Minimal Inhibitory Concentration (MIC) of Antimicrobial Substances. Nat. Protoc. 2008, 3, 163–175. DOI: 10.1038/nprot.2007.521.
   PubMed Web of Science ®Google Scholar
• Diogo, H. C.; Melhem, M.; Sarpieri, A.; Pires, M.D. Evaluation of the Disk-Diffusion Method to Determine the in Vitro Efficacy of Terbinafine against Subcutaneous and Superficial Mycoses Agents. An. Bras. Dermatol. 2010, 85, 324. DOI: 10.1590/s0365-05962010000300005.
   PubMed Web of Science ®Google Scholar
• Wayne, P. A. Clinical and Laboratory Standards Institute, performance standards for antimicrobial susceptibility testing. CLSI M2-A9, 2011, 100–121.
   Google Scholar